Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
primary studies published, non RCT
Details- 2017
- Buchs C
Recovery of lung function following a pulmonary exacerbation in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor.
primary studies published, non RCT
Details- 2017
- Flume PA
The use of telehealth (text messaging and video communications) in patients with cystic fibrosis: A pilot study.
primary studies published, non RCT
Details- 2017
- Gur M
Pregnancy among cystic fibrosis women in the era of CFTR modulators.
primary studies published, non RCT
Details- 2017
- Heltshe SL
Evaluation of quantitative PCR for early diagnosis of Pseudomonas aeruginosa infection in cystic fibrosis: a prospective cohort study.
primary studies published, non RCT
Details- 2017
- Hery-Arnaud G
Early Respiratory Bacterial Detection and Anti-Staphylococcal Antibiotic Prophylaxis in Young Children with Cystic Fibrosis.
primary studies published, non RCT
Details- 2017
- Hurley MN
Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor.
primary studies published, non RCT
Details- 2017
- Stalvey MS
Listening to motivational music while walking elicits more positive affective response in patients with cystic fibrosis
primary studies published, non RCT
Details- 2016
- Calik-Kutukcu E
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection.
primary studies published, non RCT
Details- 2016
- Elborn JS
The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study.
primary studies published, non RCT
Details- 2016
- Hanssens L